ADVM - アバランシェ・バイオテクノロジ―ズ （Adverum Biotechnologies Inc.）ADVMのニュース
Adverum Biotechnologies to Present at Upcoming Investor Conferences 2023/02/27 21:05:00 GlobeNewswire
REDWOOD CITY, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will present at the following upcoming investor conferences:
Adverum Biotechnologies Inc. (ADVM) will benefit from these strategies 2023/02/24 13:48:00 US Post News
The share price of Adverum Biotechnologies Inc. (NASDAQ:ADVM) rose to $0.70 per share on Thursday from $0.66. While Adverum Biotechnologies Inc. has overperformed by 6.50%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ADVM fell by -47.76%, with highs and lows ranging from $1.82 to $0.53, […]
Sector Stocks with Negative Change: Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), Adverum Biotechnologies, Inc. (NASDAQ:ADVM) 2023/02/21 14:42:38 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Sector Stocks with Negative Change: Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), Adverum Biotechnologies, Inc. (NASDAQ:ADVM) appeared first on Stocks Equity .
Was anything negative for Adverum Biotechnologies Inc. (ADVM) stock last session? 2023/02/09 12:40:00 US Post News
The share price of Adverum Biotechnologies Inc. (NASDAQ:ADVM) fell to $0.66 per share on Wednesday from $0.69. While Adverum Biotechnologies Inc. has underperformed by -3.95%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ADVM fell by -58.18%, with highs and lows ranging from $1.82 to $0.53, […]
Investing in Adverum Biotechnologies Inc. (ADVM) might be an excellent idea, but the stock is currently overvalued/undervalued 2022/12/28 14:08:00 US Post News
In Tuesday’s session, Adverum Biotechnologies Inc. (NASDAQ:ADVM) marked $0.54 per share, down from $0.57 in the previous session. While Adverum Biotechnologies Inc. has underperformed by -5.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ADVM fell by -70.17%, with highs and lows ranging from $2.04 to […]
Was anything negative for Adverum Biotechnologies Inc. (ADVM) stock last session? 2023/02/09 12:40:00 US Post News
The share price of Adverum Biotechnologies Inc. (NASDAQ:ADVM) fell to $0.66 per share on Wednesday from $0.69. While Adverum Biotechnologies Inc. has underperformed by -3.95%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ADVM fell by -58.18%, with highs and lows ranging from $1.82 to $0.53, […]
Investing in Adverum Biotechnologies Inc. (ADVM) might be an excellent idea, but the stock is currently overvalued/undervalued 2022/12/28 14:08:00 US Post News
In Tuesday’s session, Adverum Biotechnologies Inc. (NASDAQ:ADVM) marked $0.54 per share, down from $0.57 in the previous session. While Adverum Biotechnologies Inc. has underperformed by -5.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ADVM fell by -70.17%, with highs and lows ranging from $2.04 to […]
Adverum Biotechnologies Inc. (ADVM) did well last session? 2022/12/21 14:08:00 US Post News
Adverum Biotechnologies Inc. (NASDAQ:ADVM) closed Tuesday at $0.57 per share, down from $0.59 a day earlier. While Adverum Biotechnologies Inc. has underperformed by -2.91%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ADVM fell by -69.20%, with highs and lows ranging from $2.04 to $0.59, whereas […]
Former Merck Commercial President Dawn Svoronos joins ACELYRIN, INC. Board of Directors 2022/12/13 12:00:00 Kwhen Finance
Can you still get a good price for Adverum Biotechnologies Inc. (ADVM) Shares at this point? 2022/12/01 15:08:00 US Post News
In Wednesday’s session, Adverum Biotechnologies Inc. (NASDAQ:ADVM) marked $0.67 per share, down from $0.68 in the previous session. While Adverum Biotechnologies Inc. has underperformed by -1.50%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ADVM fell by -61.50%, with highs and lows ranging from $2.04 to […]
Can you still get a good price for Adverum Biotechnologies Inc. (ADVM) Shares at this point? 2022/12/01 15:08:00 US Post News
In Wednesday’s session, Adverum Biotechnologies Inc. (NASDAQ:ADVM) marked $0.67 per share, down from $0.68 in the previous session. While Adverum Biotechnologies Inc. has underperformed by -1.50%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ADVM fell by -61.50%, with highs and lows ranging from $2.04 to […]
Adverum Biotechnologies Inc. (ADVM) Has Great Growth Outlook For 2022 2022/11/23 14:30:00 Marketing Sentinel
Adverum Biotechnologies Inc. (NASDAQ:ADVM) has a beta value of 1.09 and has seen 5.9 million shares traded in the last trading session. The company, currently valued at $67.97M, closed the last trade at $0.69 per share which meant 0.43% during that session. The ADVM stock price is -197.1% off its 52-week high price of $2.05 … Adverum Biotechnologies Inc. (ADVM) Has Great Growth Outlook For 2022 Read More »
Adverum Biotechnologies Inc. (ADVM) can excel with these strategies 2022/11/23 12:08:00 US Post News
In Tuesday’s session, Adverum Biotechnologies Inc. (NASDAQ:ADVM) marked $0.69 per share, up from $0.69 in the previous session. While Adverum Biotechnologies Inc. has overperformed by 0.43%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ADVM fell by -64.59%, with highs and lows ranging from $2.05 to […]